Costs and cost-effectiveness of a collaborative data-to-care intervention for HIV treatment and care in the United States

被引:1
作者
Shrestha, Ram K. [1 ,2 ]
Fanfair, Robyn Neblett [2 ]
Randall, Liisa M. [3 ]
Lucas, Crystal [4 ]
Nichols, Lisa [5 ]
Camp, Nasima [2 ]
Brady, Kathleen A. [4 ]
Jenkins, Heidi [6 ]
Altice, Frederick L. [5 ]
DeMaria, Alfred [3 ]
Villanueva, Merceditas [5 ]
Weidle, Paul J. [2 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, 1600 Clifton Rd MS E 45, Atlanta, GA 30329 USA
[2] Ctr Dis Control & Prevent, Div HIV Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA
[3] Massachusetts Dept Publ Hlth, Boston, MA USA
[4] Philadelphia Dept Publ Hlth, Philadelphia, PA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] Connecticut Dept Publ Hlth, Hartford, CT USA
关键词
HIV surveillance; data-to-care; re-engagement; randomized controlled trial; economic evaluation; cost-effectiveness;
D O I
10.1002/jia2.26040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionData-to-care programmes utilize surveillance data to identify persons who are out of HIV care, re-engage them in care and improve HIV care outcomes. We assess the costs and cost-effectiveness of re-engagement in an HIV care intervention in the United States. MethodsThe Cooperative Re-engagement Control Trial (CoRECT) employed a data-to-care collaborative model between health departments and HIV care providers, August 2016-July 2018. The health departments in Connecticut (CT), Massachusetts (MA) and Philadelphia (PHL) collaborated with HIV clinics to identify newly out-of-care patients and randomize them to receive usual linkage and engagement in care services (standard-of-care control arm) or health department-initiated active re-engagement services (intervention arm). We used a microcosting approach to identify the activities and resources involved in the CoRECT intervention, separate from the standard-of-care, and quantified the costs. The cost data were collected at the start-up and recurrent phases of the trial to incorporate potential variation in the intervention costs. The costs were estimated from the healthcare provider perspective. ResultsThe CoRECT trial in CT, MA and PHL randomly assigned on average 327, 316 and 305 participants per year either to the intervention arm (n = 166, 159 and 155) or the standard-of-care arm (n = 161, 157 and 150), respectively. Of those randomized, the number of participants re-engaged in care within 90 days in the intervention and standard-of-care arms was 85 and 70 in CT, 84 and 70 in MA, and 98 and 67 in PHL. The additional number of participants re-engaged in care in the intervention arm compared with those in the standard-of-care arm was 15 (CT), 14 (MA) and 31 (PHL). We estimated the annual total cost of the CoRECT intervention at $490,040 in CT, $473,297 in MA and $439,237 in PHL. The average cost per participant enrolled was $2952, $2977 and $2834 and the average cost per participant re-engaged in care was $5765, $5634 and $4482. We estimated an incremental cost per participant re-engaged in care at $32,669 (CT), $33,807 (MA) and $14,169 (PHL). ConclusionsThe costs of the CoRECT intervention that identified newly out-of-care patients and re-engaged them in HIV care are comparable with other similar interventions, suggesting a potential for its cost-effectiveness in the US context.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review
    Simoens, Steven
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2013, 19 (06) : 1004 - 1011
  • [42] A systematic review of the cost-effectiveness of maternity models of care
    Martin, Elizabeth
    Ayoub, Bassel
    Miller, Yvette D.
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [43] Cost-effectiveness of the 'Walcheren Integrated Care Model' intervention for community-dwelling frail elderly
    Looman, Wilhelmina M.
    Huijsman, Robbert
    Bouwmans-Frijters, Clazien A. M.
    Stolk, Elly A.
    Fabbricotti, Isabelle N.
    FAMILY PRACTICE, 2016, 33 (02) : 154 - 160
  • [44] Impact of Improved HIV Care and Treatment on PrEP Effectiveness in the United States, 2016-2020
    Khurana, Nidhi
    Yaylali, Emine
    Farnham, Paul G.
    Hicks, Katherine A.
    Allaire, Benjamin T.
    Jacobson, Evin
    Sansom, Stephanie L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (04) : 399 - 405
  • [45] Expert stakeholders' perspectives on a Data-to-Care strategy for improving care among HIV-positive individuals incarcerated in jails
    Buchbinder, Mara
    Blue, Colleen
    Juengst, Eric
    Brinkley-Rubinstein, Lauren
    Rennie, Stuart
    Rosen, David L.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (09): : 1155 - 1161
  • [46] Cost-effectiveness analysis of a continuing care intervention for cocaine-dependent adults
    McCollister, Kathryn
    Yang, Xuan
    McKay, James R.
    DRUG AND ALCOHOL DEPENDENCE, 2016, 158 : 38 - 44
  • [47] Cost-effectiveness of the NIMH multisite HIV prevention intervention
    Pinkerton S.D.
    Holtgrave D.R.
    Johnson-Masotti A.P.
    Turk M.E.
    Hackl K.L.
    DiFranceisco W.
    AIDS and Behavior, 2002, 6 (1) : 83 - 96
  • [48] Living with severe multiple sclerosis: Cost-effectiveness of a palliative care intervention and cost of illness study
    Rosato, Rosalba
    Pagano, Eva
    Giordano, Andrea
    Farinotti, Mariangela
    Ponzio, Michela
    Veronese, Simone
    Confalonieri, Paolo
    Grasso, Maria Grazia
    Patti, Francesco
    Solari, Alessandra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [49] Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States
    Hutchinson, Angela B.
    Farnham, Paul G.
    Sansom, Stephanie L.
    Yaylali, Emine
    Mermin, Jonathan H.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (03) : 323 - 330
  • [50] The Cost-Effectiveness of Integrating HIV Counseling and Testing into Primary Health Care in the Ukraine
    Benjamin Johns
    Olena Doroshenko
    Lisa Tarantino
    Peter Cowley
    AIDS and Behavior, 2017, 21 : 655 - 664